ArticleJapanese journal of clinical oncology2025

Selumetinib for symptomatic, inoperable plexiform neurofibromas in pediatric patients with neurofibromatosis type 1: the first single-center real-world case series in Japan.

Yoshihiro Nishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.